. 2005 Jan 7;11(1):104–108. doi: 10.3748/wjg.v11.i1.104

Table 2.

Changes of gastric inflammation induced by rofecoxib between H pylori-infected, H pylori-eradicated and H pylori-uninfected gerbils.

H pylori-infected	H pylori-eradicated	H pylori-uninfected	P
Stomach weight ratio (×1000)	12.8±0.4	10.1±0.3	8.1±0.4	<0.05^a
				<0.05^c
Hyperplasia area (mm²)	30.5±5.1	1.3±0.6	0	<0.05^a
				<0.05^c
Erosion and ulcer area (mm²)	1.3±0.6	0.4±0.3	0	<0.05^a
				<0.05^c
Score of gastritis	7.0±0.0	2.7±0.5	0	<0.05^a
				<0.05^c
MPO activity (mmoL H₂O₂/min/g tissue)	133.5±15.0	2.9±0.7	6.6±1.7	<0.05^a
				<0.05^c
PGE₂ synthesis (pg/mg wet weight/min)	321.4±30.3	11.9±4.8	25.9±15.9	<0.05^a
				<0.05^c

Stomach weight ratio: weight of stomach to weight of body ^aP<0.05, H pylori-infected vs H pylori-eradicated; ^cP<0.05, H pylori- infected vs H pylori uninfected.